STAT — Reporting from the frontiers of health and medicine
- Health In ‘chemo brain,’ researchers see clues to unravel long Covid’s brain fog
- First Opinion Maximizing kidney transplant equity means minimizing geography
- Biotech Biogen sells stake in Samsung venture for $2.3 billion
- The Readout LOUD ‘There’s no free lunch with drugs’: Janet Woodcock talks Covid monoclonal antibodies and pediatric vaccines
- First Opinion Break the stranglehold of the doctor-patient visit on health care innovation
- Health In ‘chemo brain,’ researchers see clues to unravel long Covid’s brain fog
- First Opinion Maximizing kidney transplant equity means minimizing geography
- Biotech Biogen sells stake in Samsung venture for $2.3 billion
- The Readout LOUD ‘There’s no free lunch with drugs’: Janet Woodcock talks Covid monoclonal antibodies and pediatric vaccines
- First Opinion Break the stranglehold of the doctor-patient visit on health care innovation
Exclusive analysis of biotech, pharma, and the life sciences
- The Readout LOUD ‘There’s no free lunch with drugs’: Janet Woodcock talks Covid monoclonal antibodies and pediatric vaccines
- Health In ‘chemo brain,’ researchers see clues to unravel long Covid’s brain fog
- First Opinion Researching collagen to help his achy knees, a statistician explores the painfully weak evidence
-
- Biotech ‘Nowhere to hide’: As biotech stocks plummet, an industry is being reshaped by the fallout
- Health The Covid-19 Tracker
- Health Early data indicate vaccines still protect against Omicron’s sister variant, BA.2
- Health Tech Once billed as a revolution in medicine, IBM’s Watson Health is sold off in parts
- Special Report The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race
